Fingerprint Dive into the research topics of 'Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: A California cancer consortium phase II trial'. Together they form a unique fingerprint.